CENTER-AL – DACTYLIS GLOMERATA POLLEN (ALK-Abello, Inc.)
Welcome to the PulseAid listing for the CENTER-AL – DACTYLIS GLOMERATA POLLEN drug offered from ALK-Abello, Inc.. This Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] pharmaceutical is classified as a NON-STANDARDIZED ALLERGENIC. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same NON-STANDARDIZED ALLERGENIC drug type category.
| LABELER NAME / MANUFACTURER: | ALK-Abello, Inc. |
| NON-PROPRIETARY NAME: | Allergenic Extracts Alum Precipitated |
| SUBSTANCE NAME: | DACTYLIS GLOMERATA POLLEN |
| TYPE: | NON-STANDARDIZED ALLERGENIC |
| PHARMA CLASS: | Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SUSPENSION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1975-01-15 |
| END MARKETING DATE: | 0000-00-00 |
CENTER-AL – DACTYLIS GLOMERATA POLLEN NON-STANDARDIZED ALLERGENIC Details:
| Item Description | CENTER-AL – DACTYLIS GLOMERATA POLLEN from ALK-Abello, Inc. |
| LABELER NAME: | ALK-Abello, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20000([PNU]/mL) |
| START MARKETING DATE: | 1975-01-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0268-0134_5c1a4f73-cd9d-408a-9de5-206efa183701 |
| PRODUCT NDC: | 0268-0134 |
| APPLICATION NUMBER: | BLA103753 |
Other DACTYLIS GLOMERATA POLLEN Pharmaceutical Manufacturers / Labelers:
